8-chloro-3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazine;(3-chloropyrazin-2-yl)methanamine;N-[(3-chloropyrazin-2-yl)methyl]-2,3-difluorobenzamide;2,3-difluorobenzoic acid;5-[3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide;N-(4-fluorophenyl)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
C82H64BCl3F10N14O7 — CID 157055126
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-chloro-3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazine;(3-chloropyrazin-2-yl)methanamine;N-[(3-chloropyrazin-2-yl)methyl]-2,3-difluorobenzamide;2,3-difluorobenzoic acid;5-[3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide;N-(4-fluorophenyl)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
8-chloro-3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazine;(3-chloropyrazin-2-yl)methanamine;N-[(3-chloropyrazin-2-yl)methyl]-2,3-difluorobenzamide;2,3-difluorobenzoic acid;5-[3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide;N-(4-fluorophenyl)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (PubChem CID 157055126) has the molecular formula C82H64BCl3F10N14O7 and a molecular weight of 1664.66 g/mol. Its IUPAC name is 8-chloro-3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazine;(3-chloropyrazin-2-yl)methanamine;N-[(3-chloropyrazin-2-yl)methyl]-2,3-difluorobenzamide;2,3-difluorobenzoic acid;5-[3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide;N-(4-fluorophenyl)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide.
Molecular Properties
| Compound Name | 8-chloro-3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazine;(3-chloropyrazin-2-yl)methanamine;N-[(3-chloropyrazin-2-yl)methyl]-2,3-difluorobenzamide;2,3-difluorobenzoic acid;5-[3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide;N-(4-fluorophenyl)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide |
|---|---|
| PubChem CID | 157055126 |
| Molecular Formula | C82H64BCl3F10N14O7 |
| Molecular Weight | 1664.66 g/mol |
| Exact Mass | 1662.41 |
| IUPAC Name | 8-chloro-3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazine;(3-chloropyrazin-2-yl)methanamine;N-[(3-chloropyrazin-2-yl)methyl]-2,3-difluorobenzamide;2,3-difluorobenzoic acid;5-[3-(2,3-difluorophenyl)imidazo[1,5-a]pyrazin-8-yl]-N-(4-fluorophenyl)-2-methylbenzamide;N-(4-fluorophenyl)-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide |
| SMILES | Cc1ccc(-c2nccn3c(-c4cccc(F)c4F)ncc23)cc1C(=O)Nc1ccc(F)cc1.Cc1ccc(B2OC(C)(C)C(C)(C)O2)cc1C(=O)Nc1ccc(F)cc1.Fc1cccc(-c2ncc3c(Cl)nccn23)c1F.NCc1nccnc1Cl.O=C(NCc1nccnc1Cl)c1cccc(F)c1F.O=C(O)c1cccc(F)c1F |
| InChI | InChI=1S/C26H17F3N4O.C20H23BFNO3.C12H8ClF2N3O.C12H6ClF2N3.C7H4F2O2.C5H6ClN3/c1-15-5-6-16(13-20(15)26(34)32-18-9-7-17(27)8-10-18)24-22-14-31-25(33(22)12-11-30-24)19-3-2-4-21(28)23(19)29;1-13-6-7-14(21-25-19(2,3)20(4,5)26-21)12-17(13)18(24)23-16-10-8-15(22)9-11-16;13-11-9(16-4-5-17-11)6-18-12(19)7-2-1-3-8(14)10(7)15;13-11-9-6-17-12(18(9)5-4-16-11)7-2-1-3-8(14)10(7)15;8-5-3-1-2-4(6(5)9)7(10)11;6-5-4(3-7)8-1-2-9-5/h2-14H,1H3,(H,32,34);6-12H,1-5H3,(H,23,24);1-5H,6H2,(H,18,19);1-6H;1-3H,(H,10,11);1-2H,3,7H2 |
| InChIKey | AAQWFAGLIFGMIC-UHFFFAOYSA-N |
| XLogP | 17.64 |
| TPSA | 281.02 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 117 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1664.66 |
| LogP ≤ 5 | 17.64 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157055126 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.